Sun Pharma will receive from Cassiopea the exclusive right to develop and commercialize WINLEVI in Japan, Australia, New Zealand, Brazil, Mexico and Russia.
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
Merck’s first microbiology application and training lab in India
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
WuXi STA opens a new large scale continuous manufacturing plant
Better serving global partners and advancing healthcare innovation
With this, the company can start selling Ibuprofen in the European markets.
Company raises the annual revenue guidance from mid-teens to high teens
DS-7300 is a specifically designed potential first-in-class B7-H3 directed antibody drug conjugate
Subscribe To Our Newsletter & Stay Updated
